David Béchard
Gründer bei Cytune Pharma SAS
Ursprung des Netzwerks ersten Grades von David Béchard
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Béchard
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
DMS Biotechnology SRL
 DMS Biotechnology SRL BiotechnologyHealth Technology DMS Biotechnology Sprl develops biotechnology products. The private company is based in Mont-Saint-Guibert, Belgium. | Biotechnology | Corporate Officer/Principal | |
| Vrije Universiteit Brussel | College/University | Doctorate Degree | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Corporate Officer/Principal | |
Remora Partners SA
 Remora Partners SA Financial ConglomeratesFinance Remora Partners SA operates as an investment advisor. The private company is based in Lausanne, CH. and has subsidiaries in Switzerland and United States. | Financial Conglomerates | Corporate Officer/Principal | |
| Institute Gustave Rousse | Corporate Officer/Principal | ||
| Hôpital Européen Georges-pompidou | Corporate Officer/Principal | ||
| University of Geneva | College/University | Graduate Degree | |
BioLingus (Cayman) Ltd.
 BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Miscellaneous Commercial Services | Founder | |
| University of Nantes | College/University | Corporate Officer/Principal |
Statistik
International
| Frankreich | 6 |
| Belgien | 4 |
| Schweiz | 3 |
| Cayman Islands | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Operativ
| Corporate Officer/Principal | 9 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Guy de Martynoff | 9 |
| Didier Coquoz | 3 |
| Yannick Jacques | 2 |
- Börse
- Insiders
- David Béchard
- Unternehmensverbindungen
